-
Does Puma's quick launch play into its buyout prospects? | Fierce Pharma
-
Puma PHARMA
-
(@pumabiotech) /
-
Resumen: Puma Biotechnology y Fabre el acuerdo licencia de NERLYNX® para incluir la Gran China | Business
-
Biotechnology
-
Puma PHARMA
-
Hering Pharma Muira Tincture Q 30ml ShopHealthy.in
-
Puma Biotech Strikes Deal to Develop its Breast Cancer Drug in China - Los Business Journal
-
Puma – PHARMA
-
Resumen: Puma Biotechnology y Fabre el acuerdo licencia de NERLYNX® para incluir la Gran China | Business
-
Puma Biotech In-Licenses Takeda's Cancer Candidate With Focus On & Lung Cancer
-
Resumen: Biotechnology y Pierre Fabre firman acuerdo de licencia exclusiva para desarrollar y NERLYNX® (neratinib) en Europa | Business
-
Puma Biotechnology 11-6 Scripps CME Connection
-
Puma PHARMA
-
Puma Too Little, Too Late, Much Of Bad Side Effect (NASDAQ:PBYI) | Seeking
-
Biotechnology
-
Medical Affairs eLearning -
-
Puma Biotechnology, | LinkedIn
-
Biotechnology Surging
-
Ex-Puma exec charged with insider trading, hit with criminal | Fierce Biotech
-
Puma Pharma (@PumaPharma) Twitter
-
La EMA no aprobar el de Biotech
-
BIOTECHNOLOGY, FORM 10-K - Biotech Due Diligence
-
Puma Wins Extension of Patent Main Breast Treatment Drug Nerlynx - Los Angeles Journal
-
Biotechnology